Doug Rosendale

Dr. Doug Rosendale


Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
6 March 2020 in Metabolites
Verified
Journal Article
Open access
PDF file
Rohan ShahRohan Shah
Rohan Shah
EMElizabeth McKenzie
Elizabeth McKenzie
MRMagda Teresa Rosin
Magda Teresa Rosin
Snehal JadhavSnehal Jadhav
Snehal Jadhav
SGShakuntla Gondalia
Shakuntla Gondalia
David BealeDavid Beale
David Beale
Our understanding of the human gut microbiome has grown exponentially. Advances in genome sequencing technologies and metagenomics analysis have enabled researchers to study microbial communities and their potential function within the context of a range of human gut related diseases and disorders. However, up until recently, much of this research has focused on characterizing the gut microbiological community structure and understanding its potential through system wide (meta) genomic and transcriptomic-based studies. Thus far, the functional output of these microbiomes, in terms of protein and metabolite expression, and within the broader context of host-gut microbiome interactions, has been limited. Furthermore, these studies highlight our need to address the issues of individual variation, and of samples as proxies. Here we provide a perspective review of the recent literature that focuses on the challenges of exploring the human gut microbiome, with a strong focus on an integrated perspective applied to these themes. In doing so, we contextualize the experimental and technical challenges of undertaking such studies and provide a framework for capitalizing on the breadth of insight such approaches afford. An integrated perspective of the human gut microbiome and the linkages to human health will pave the way forward for delivering against the objectives of precision medicine, which is targeted to specific individuals and addresses the issues and mechanisms in situ.

3 October 2021 in Microorganisms
Verified
Journal Article
Open access
PDF file
SPShanthi G. Parkar
Shanthi G. Parkar
DRDoug Rosendale
Doug Rosendale
HSHalina Stoklosinski
Halina Stoklosinski
CJCarel Jobsis
Carel Jobsis
DHDuncan Iain Hedderley
Duncan Iain Hedderley
Pramod GopalPramod Gopal
Pramod Gopal
We examined the prebiotic potential of 32 food ingredients on the developing infant microbiome using an in vitro gastroileal digestion and colonic fermentation model. There were significant changes in the concentrations of short-chain fatty-acid metabolites, confirming the potential of the tested ingredients to stimulate bacterial metabolism. The 16S rRNA gene sequencing for a subset of the ingredients revealed significant increases in the relative abundances of the lactate- and acetate-producing Bifidobacteriaceae, Enterococcaceae, and Lactobacillaceae, and lactate- and acetate-utilizing Prevotellaceae, Lachnospiraceae, and Veillonellaceae. Selective changes in specific bacterial groups were observed. Infant whole-milk powder and an oat flour enhanced Bifidobacteriaceae and lactic acid bacteria. A New Zealand-origin spinach powder enhanced Prevotellaceae and Lachnospiraceae, while fruit and vegetable powders increased a mixed consortium of beneficial gut microbiota. All food ingredients demonstrated a consistent decrease in Clostridium perfringens, with this organism being increased in the carbohydrate-free water control. While further studies are required, this study demonstrates that the selected food ingredients can modulate the infant gut microbiome composition and metabolism in vitro. This approach provides an opportunity to design nutrient-rich complementary foods that fulfil infants’ growth needs and support the maturation of the infant gut microbiome.

17 February 2022 in Animals
Verified
Journal Article
Open access
PDF file
CBChristina Frances Butowski
Christina Frances Butowski
DTDavid Thomas
David Thomas
NCNick J. Cave
Nick J. Cave
EBEmma Bermingham
Emma Bermingham
DRDoug Rosendale
Doug Rosendale
WYWayne Young
Wayne Young
The gastrointestinal microbiome has a range of roles in the host, including the production of beneficial fermentation end products such as butyrate, which are typically associated with fermentation of plant fibres. However, domestic cats are obligate carnivores and do not require carbohydrates. It has been hypothesised that in the wild, collagenous parts of prey—the so-called animal-derived fermentable substrates (ADFS) such as tendons and cartilage—may be fermented by the cat’s gastrointestinal microbiome. However, little research has been conducted on ADFS in the domestic cat. Faecal inoculum was obtained from domestic cats either consuming a high carbohydrate (protein:fat:carbohydrate ratio of 35:20:28 (% dry matter basis)) or high protein (protein:fat:carbohydrate ratio of 75:19:1 (% dry matter basis)) diet. ADFS (hydrolysed collagen, cat hair, and cartilage) were used in a series of static in vitro digestions and fermentations. Concentrations of organic acids and ammonia were measured after 24 h of fermentation, and the culture community of microbes was characterised. The type of inoculum used affected the fermentation profile produced by the ADFS. Butyrate concentrations were highest when hydrolysed collagen was fermented with high protein inoculum (p < 0.05). In contrast, butyrate was not detectable when hydrolysed collagen was fermented in high carbohydrate inoculum (p < 0.05). The microbiome of the domestic cat may be able to ferment ADFS to provide beneficial concentrations of butyrate.

14 September 2023
Verified
Book Chapter
Closed access
PDF file
Noha NasefNoha Nasef
Noha Nasef
DRDoug Rosendale
Doug Rosendale
SMStarin McKeen
Starin McKeen

9 November 2022
Verified
Book Chapter
Closed access
PDF file
Noha NasefNoha Nasef
Noha Nasef
DRDoug Rosendale
Doug Rosendale
SMStarin McKeen
Starin McKeen